ETOMIDATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Etomidate, and what generic alternatives are available?
Etomidate is a drug marketed by Avet Lifesciences, Caplin, Endo Operations, Eugia Pharma, Gland Pharma Ltd, Hikma, Luitpold, Mylan Labs Ltd, Rising, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in ETOMIDATE is etomidate. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Etomidate
A generic version of ETOMIDATE was approved as etomidate by HIKMA on November 4th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETOMIDATE?
- What are the global sales for ETOMIDATE?
- What is Average Wholesale Price for ETOMIDATE?
Summary for ETOMIDATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 100 |
| Patent Applications: | 5,080 |
| Drug Prices: | Drug price information for ETOMIDATE |
| DailyMed Link: | ETOMIDATE at DailyMed |
Recent Clinical Trials for ETOMIDATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ahon Pharmaceutical Co., Ltd. | Phase 1 |
| Hartford Hospital | Phase 4 |
| Jason Chui | Phase 4 |
Pharmacology for ETOMIDATE
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for ETOMIDATE
Anatomical Therapeutic Chemical (ATC) Classes for ETOMIDATE
US Patents and Regulatory Information for ETOMIDATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 204618-001 | Aug 13, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 202354-001 | Feb 25, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 206126-001 | Feb 24, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Luitpold | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 078867-001 | Dec 22, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Caplin | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 215028-001 | Dec 18, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 091297-001 | Jun 20, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 074593-001 | Nov 4, 1996 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
